OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial
Hatem Soliman, Deanna Hogue, Hyo S. Han, et al.
Nature Medicine (2023)
Open Access | Times Cited: 48
Hatem Soliman, Deanna Hogue, Hyo S. Han, et al.
Nature Medicine (2023)
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Therapeutic cancer vaccines: advancements, challenges and prospects
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 148
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 148
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
Md Abdus Subhan, Farzana Parveen, Hassan Shah, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2204-2204
Open Access | Times Cited: 40
Md Abdus Subhan, Farzana Parveen, Hassan Shah, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2204-2204
Open Access | Times Cited: 40
Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
Charalampos Filippou, Sophia C. Themistocleous, Giorgos Marangos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1110-1110
Open Access | Times Cited: 12
Charalampos Filippou, Sophia C. Themistocleous, Giorgos Marangos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1110-1110
Open Access | Times Cited: 12
Oncolytic virus-based combination therapy in breast cancer
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Cancer Letters (2024) Vol. 585, pp. 216634-216634
Open Access | Times Cited: 11
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Cancer Letters (2024) Vol. 585, pp. 216634-216634
Open Access | Times Cited: 11
Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity
Shuo Wang, An Song, Jun Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Shuo Wang, An Song, Jun Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
Yalei Zhang, Ling Qian, Kun Chen, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 2000-2020
Open Access | Times Cited: 6
Yalei Zhang, Ling Qian, Kun Chen, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 2000-2020
Open Access | Times Cited: 6
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial)
Julia Maria Ressler, Maud Plaschka, Rita Silmbrod, et al.
Nature Cancer (2025)
Open Access
Julia Maria Ressler, Maud Plaschka, Rita Silmbrod, et al.
Nature Cancer (2025)
Open Access
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial
Zhichao Tan, Yan Sheng Wu, Zhengfu Fan, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010543-e010543
Open Access
Zhichao Tan, Yan Sheng Wu, Zhengfu Fan, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010543-e010543
Open Access
Clinical trials on oncolytic viruses
I.V. Golovinov, А. С. Гончарова, A. A. Shulga, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 158-168
Open Access
I.V. Golovinov, А. С. Гончарова, A. A. Shulga, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 158-168
Open Access
Tumor microbiome: roles in tumor initiation, progression, and therapy
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Novel immunotherapies for breast cancer: Focus on 2023 findings
Huanrong Lan, Min Chen, Shi-Ya Yao, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111549-111549
Closed Access | Times Cited: 5
Huanrong Lan, Min Chen, Shi-Ya Yao, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111549-111549
Closed Access | Times Cited: 5
New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 5
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 5
Recent Advances in Immunotherapy for Breast Cancer: A Review
Qian-Er Wen, Liang Li, Rui-Qi Feng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 497-516
Open Access | Times Cited: 4
Qian-Er Wen, Liang Li, Rui-Qi Feng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 497-516
Open Access | Times Cited: 4
A protracted war against cancer drug resistance
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 4
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 4
Potential targeting of the tumor microenvironment to improve cancer virotherapy
Zi‐Xian Liao, Shan‐hui Hsu, Shiue–Cheng Tang, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108521-108521
Closed Access | Times Cited: 10
Zi‐Xian Liao, Shan‐hui Hsu, Shiue–Cheng Tang, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108521-108521
Closed Access | Times Cited: 10
Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses
Michael L. Monaco, Omer A. Idris, Karim Essani
Cancers (2023) Vol. 15, Iss. 8, pp. 2393-2393
Open Access | Times Cited: 9
Michael L. Monaco, Omer A. Idris, Karim Essani
Cancers (2023) Vol. 15, Iss. 8, pp. 2393-2393
Open Access | Times Cited: 9
The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer
Prarthna V Bhardwaj, Yara Abdou
The Oncologist (2023) Vol. 28, Iss. 10, pp. 832-844
Open Access | Times Cited: 8
Prarthna V Bhardwaj, Yara Abdou
The Oncologist (2023) Vol. 28, Iss. 10, pp. 832-844
Open Access | Times Cited: 8
Immunotherapeutic Agents for Intratumoral Immunotherapy
Chih‐Rong Shyr, L Liu, Hui-Shan Chien, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1717-1717
Open Access | Times Cited: 8
Chih‐Rong Shyr, L Liu, Hui-Shan Chien, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1717-1717
Open Access | Times Cited: 8
Gadolinium‐Manganese‐Based Nanoplatform Reverses Radiotherapy Resistant Factors for Radiotherapy Sensitization and Computed Tomography/Magnetic Resonance Dual‐Modal Imaging
Yingwen Li, Panhong Niu, Zhenzhong Han, et al.
Small Structures (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 2
Yingwen Li, Panhong Niu, Zhenzhong Han, et al.
Small Structures (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 2
